These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16503182)

  • 1. Isolates of Candida albicans that differ in virulence for mice elicit strain-specific antibody-mediated protective responses.
    Hu Y; Farah CS; Ashman RB
    Microbes Infect; 2006 Mar; 8(3):612-20. PubMed ID: 16503182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans.
    Wanasaengsakul S; Ashman RB
    Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune responses to systemic Candida albicans infection in inbred mouse strains.
    Costantino PJ; Gare NF; Warmington JR
    Immunol Cell Biol; 1995 Apr; 73(2):125-33. PubMed ID: 7797232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein.
    Tavares D; Ferreira P; Arala-Chaves M
    Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans.
    Hu Y; Farah CS; Ashman RB
    Immunol Cell Biol; 2006 Oct; 84(5):455-60. PubMed ID: 16869942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased tissue resistance in the nude mouse against Candida albicans without altering strain-dependent differences in susceptibility.
    Fulurija A; Ashman RB; Papadimitriou JM
    J Med Vet Mycol; 1997; 35(3):197-203. PubMed ID: 9229336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of a monoclonal antibody for the detection of Candida antigens in an experimental systemic candidiasis model.
    Wong SF; Mak JW; Pook CK
    Hybridoma (Larchmt); 2008 Oct; 27(5):361-73. PubMed ID: 18823263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain differences in the severity of lesions in murine systemic candidiasis correlate with the production of functional gamma interferon by Candida-activated lymphocytes in vitro.
    Ashman RB; Bolitho EM
    Lymphokine Cytokine Res; 1993 Dec; 12(6):471-6. PubMed ID: 8123764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection.
    Ashman RB
    Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():15-20. PubMed ID: 2180815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against systemic infections with various Candida species elicited by vaccination with Candida albicans ribosomes.
    Segal E; Nussbaum S; Barr-Nea L
    Sabouraudia; 1985 Aug; 23(4):275-85. PubMed ID: 3901330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of a monoclonal antibody against mannoprotein of Candida albicans.
    Farahnejad Z; Rasaee MJ; Moghadam MF; Paknejad M; Kashanian S; Rajabi M
    Hybridoma (Larchmt); 2005 Jun; 24(3):146-51. PubMed ID: 15943562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.
    Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to Candida albicans in genetically distinct mice.
    Hector RF; Domer JE; Carrow EW
    Infect Immun; 1982 Dec; 38(3):1020-8. PubMed ID: 6759403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both CD4+ and CD8+ lymphocytes reduce the severity of tissue lesions in murine systemic cadidiasis, and CD4+ cells also demonstrate strain-specific immunopathological effects.
    Ashman RB; Fulurija A; Papadimitriou JM
    Microbiology (Reading); 1999 Jul; 145 ( Pt 7)():1631-1640. PubMed ID: 10439402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic and protective Candida albicans constituents.
    Cassone A; De Bernardis F; Ausiello CM; Gomez MJ; Boccanera M; La Valle R; Torosantucci A
    Res Immunol; 1998; 149(4-5):289-99; discussion 504. PubMed ID: 9720947
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic significance of diverse specificity of monoclonal antibodies against mannans of Candida albicans.
    Kagaya K; Miyakawa Y; Fujihara H; Suzuki M; Soe G; Fukazawa Y
    J Immunol; 1989 Nov; 143(10):3353-8. PubMed ID: 2681415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.